Hedge Fund and Insider Trading News: Jeff Smith, Dan Loeb, Warren Buffett, Toscafund Asset Management, Workday Inc (WDAY), Dicks Sporting Goods Inc (DKS), and More

Pictet Seizes on Global Stock Market Mispricing Surge With New Hedge Fund Launch (Hedge Week)
Pictet Asset Management, the investment management arm of Geneva-headquartered wealth management giant Pictet Group, is tapping into the surge in global stock market mispricings with a new hedge fund strategy that takes a higher risk, higher return approach. The Pictet TR-Atlas Titan fund is a directional long/short global equity strategy which trades on opportunities arising out of mispriced equities across both developing and emerging markets, using a mix of top-down macro analysis of business cycles across geographies and sectors and bottom-up fundamental stock selection.

Workday Inc (WDAY) Co-CEO Aneel Bhusri Sold $19.6 million of Shares (Guru Focus)
Co-CEO of Workday Inc., Aneel Bhusri, sold 88,339 shares of WDAY on 10/05/2020 at an average price of $221.73 a share. The total sale was $19.6 million. Workday Inc is a SaaS provider offering enterprise resource planning, or ERP, software for medium and large enterprises. The company’s product portfolio is built around human capital and financial management software.

A Director at Dick’s Sporting Goods (NYSE: DKS) is Selling Shares (Analyst Ratings)
Yesterday, a Director at Dick’s Sporting Goods (DKS), William Colombo, sold shares of DKS for $555.8K. Following William Colombo’s last DKS Sell transaction on March 16, 2020, the stock climbed by 39.4%. In addition to William Colombo, 4 other DKS executives reported Sell trades in the last month.

Insider Sells Novagold Resources Shares (Benzinga)
Dowdall Sharon filed a Form 4 with the SEC on Wednesday, October 7. The insider sold 72,465 shares of Novagold Resources Inc. (AMEX:NG) at an average price of $11.18. After the transaction, the executive’s stake in Novagold Resources Inc. moved to 34,806 shares. Novagold Resources was trading 1.4% higher from the previous closing price.

Ptc Therapeutics Inc (PTCT) CEO Stuart Walter Peltz Sold $9 million of Shares (Guru Focus)
CEO of Ptc Therapeutics Inc., Stuart Walter Peltz, sold 179,811 shares of PTCT on 10/06/2020 at an average price of $50.09 a share. The total sale was $9 million. PTC Therapeutics Inc is a biopharmaceutical company. It is focused on the discovery and development of orally administered, proprietary small-molecule drugs that target post-transcriptional control processes.